Cargando…
The Biomarkers for Acute Myocardial Infarction and Heart Failure
The use of a large number of cardiovascular biomarkers, meant to complement the use of the electrocardiogram, echocardiography cardiac imaging, and clinical symptom assessment, has become a routine in clinical diagnosis, differential diagnosis, risk stratification, and prognosis and guides the manag...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988690/ https://www.ncbi.nlm.nih.gov/pubmed/32016113 http://dx.doi.org/10.1155/2020/2018035 |
_version_ | 1783492300334170112 |
---|---|
author | Wang, Xi-Ying Zhang, Fen Zhang, Chi Zheng, Liang-Rong Yang, Jian |
author_facet | Wang, Xi-Ying Zhang, Fen Zhang, Chi Zheng, Liang-Rong Yang, Jian |
author_sort | Wang, Xi-Ying |
collection | PubMed |
description | The use of a large number of cardiovascular biomarkers, meant to complement the use of the electrocardiogram, echocardiography cardiac imaging, and clinical symptom assessment, has become a routine in clinical diagnosis, differential diagnosis, risk stratification, and prognosis and guides the management of patients with suspected cardiovascular diseases. There is a broad consensus that cardiac troponin and natriuretic peptides are the preferred biomarkers in clinical practice for the diagnosis of the acute coronary syndrome and heart failure, respectively, while the roles and possible clinical applications of several other potential biomarkers are still under study. This review mainly focuses on the recent studies of the roles and clinical applications of troponin and natriuretic peptides, which seem to be the best-validated markers in distinguishing and predicting the future cardiac events of patients with suspected cardiovascular diseases. Additionally, the review briefly discusses some of the large number of potential markers that may play a more prominent role in the future. |
format | Online Article Text |
id | pubmed-6988690 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-69886902020-02-03 The Biomarkers for Acute Myocardial Infarction and Heart Failure Wang, Xi-Ying Zhang, Fen Zhang, Chi Zheng, Liang-Rong Yang, Jian Biomed Res Int Review Article The use of a large number of cardiovascular biomarkers, meant to complement the use of the electrocardiogram, echocardiography cardiac imaging, and clinical symptom assessment, has become a routine in clinical diagnosis, differential diagnosis, risk stratification, and prognosis and guides the management of patients with suspected cardiovascular diseases. There is a broad consensus that cardiac troponin and natriuretic peptides are the preferred biomarkers in clinical practice for the diagnosis of the acute coronary syndrome and heart failure, respectively, while the roles and possible clinical applications of several other potential biomarkers are still under study. This review mainly focuses on the recent studies of the roles and clinical applications of troponin and natriuretic peptides, which seem to be the best-validated markers in distinguishing and predicting the future cardiac events of patients with suspected cardiovascular diseases. Additionally, the review briefly discusses some of the large number of potential markers that may play a more prominent role in the future. Hindawi 2020-01-16 /pmc/articles/PMC6988690/ /pubmed/32016113 http://dx.doi.org/10.1155/2020/2018035 Text en Copyright © 2020 Xi-Ying Wang et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Wang, Xi-Ying Zhang, Fen Zhang, Chi Zheng, Liang-Rong Yang, Jian The Biomarkers for Acute Myocardial Infarction and Heart Failure |
title | The Biomarkers for Acute Myocardial Infarction and Heart Failure |
title_full | The Biomarkers for Acute Myocardial Infarction and Heart Failure |
title_fullStr | The Biomarkers for Acute Myocardial Infarction and Heart Failure |
title_full_unstemmed | The Biomarkers for Acute Myocardial Infarction and Heart Failure |
title_short | The Biomarkers for Acute Myocardial Infarction and Heart Failure |
title_sort | biomarkers for acute myocardial infarction and heart failure |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988690/ https://www.ncbi.nlm.nih.gov/pubmed/32016113 http://dx.doi.org/10.1155/2020/2018035 |
work_keys_str_mv | AT wangxiying thebiomarkersforacutemyocardialinfarctionandheartfailure AT zhangfen thebiomarkersforacutemyocardialinfarctionandheartfailure AT zhangchi thebiomarkersforacutemyocardialinfarctionandheartfailure AT zhengliangrong thebiomarkersforacutemyocardialinfarctionandheartfailure AT yangjian thebiomarkersforacutemyocardialinfarctionandheartfailure AT wangxiying biomarkersforacutemyocardialinfarctionandheartfailure AT zhangfen biomarkersforacutemyocardialinfarctionandheartfailure AT zhangchi biomarkersforacutemyocardialinfarctionandheartfailure AT zhengliangrong biomarkersforacutemyocardialinfarctionandheartfailure AT yangjian biomarkersforacutemyocardialinfarctionandheartfailure |